{
  "guideline_id": "I.C.1.g.1.j",
  "semantic_title": "Coding Guidelines for Follow-up Visits After COVID-19 Infection Has Resolved",
  "section_path": "Section I > C. Chapter-Specific Coding Guidelines > 1. Chapter 1: Certain Infectious and Parasitic Diseases > g. Coronavirus infections > 1. COVID-19 infections > j. Follow-up visits after COVID-19 infection has resolved",
  "page_number": 31,
  "content": {
    "full_text": "For individuals who previously had COVID-19, without residual symptom(s) or condition(s), and are being seen for follow-up evaluation, and COVID-19 test results are negative, assign codes Z09, Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm, and Z86.16, Personal history of COVID-19. For follow-up visits for individuals with symptom(s) or condition(s) related to a previous COVID-19 infection, see guideline I.C.1.g.1.m. See Section I.C.21.c.8, Factors influencing health states and contact with health services, Follow-up (Evidence: pg no: 31, L40-L45)",
    "summary": "Provides coding instructions for follow-up visits after resolved COVID-19 infection, distinguishing between patients with and without residual symptoms (Evidence: pg no: 31, L40-L45)",
    "key_concepts": [
      "Follow-up coding for resolved COVID-19 (Evidence: pg no: 31, L40-L43)",
      "Negative test results requirement (Evidence: pg no: 31, L42)",
      "No residual symptoms condition (Evidence: pg no: 31, L41-L42)",
      "Dual code assignment Z09 and Z86.16 (Evidence: pg no: 31, L42-L43)"
    ],
    "detailed_rules": [
      {
        "rule_id": "COVID_FOLLOWUP_01",
        "rule_text": "Assign Z09 and Z86.16 for follow-up visits after resolved COVID-19 without residual symptoms (Evidence: pg no: 31, L42-L43)",
        "explanation": "For patients who previously had COVID-19, have no residual symptoms or conditions, are being seen for follow-up evaluation, and have negative COVID-19 test results, assign both Z09 and Z86.16 (Evidence: pg no: 31, L40-L43)",
        "importance": "high",
        "applies_to": "Z09, Z86.16",
        "common_applications": [
          "Post-COVID follow-up appointments",
          "Routine monitoring after COVID-19 recovery"
        ]
      },
      {
        "rule_id": "COVID_FOLLOWUP_02",
        "rule_text": "Different coding applies for follow-up visits with residual symptoms (Evidence: pg no: 31, L44-L45)",
        "explanation": "For follow-up visits where individuals have symptoms or conditions related to previous COVID-19 infection, refer to guideline I.C.1.g.1.m for appropriate coding (Evidence: pg no: 31, L44-L45)",
        "importance": "high",
        "applies_to": "Post COVID-19 conditions",
        "common_applications": [
          "Long COVID follow-up",
          "Post-COVID complications"
        ]
      }
    ],
    "workflow_steps": [
      "Step 1: Determine if patient previously had COVID-19",
      "Step 2: Assess for residual symptoms or conditions",
      "Step 3: Verify negative COVID-19 test results",
      "Step 4: If no residual symptoms and negative tests, assign Z09 and Z86.16",
      "Step 5: If residual symptoms present, refer to guideline I.C.1.g.1.m"
    ],
    "related_terminology": [
      "follow-up examination",
      "residual symptoms",
      "negative test results",
      "completed treatment"
    ]
  },
  "code_references": {
    "code_ranges": [],
    "specific_codes": [
      {
        "code": "Z09",
        "description": "Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm (Evidence: pg no: 31, L42-L43)",
        "context": "For follow-up after resolved COVID-19 without residual symptoms",
        "requires_additional_codes": true,
        "breakdown": {
          "Z09": "Follow-up examination after completed treatment"
        }
      },
      {
        "code": "Z86.16",
        "description": "Personal history of COVID-19 (Evidence: pg no: 31, L43)",
        "context": "Used with Z09 for COVID-19 follow-up visits",
        "requires_additional_codes": true,
        "breakdown": {
          "Z86": "Personal history of certain other diseases",
          ".16": "Personal history of COVID-19"
        }
      }
    ],
    "code_patterns": [
      {
        "pattern": "Z09 + Z86.16",
        "description": "Dual coding for COVID-19 follow-up without residual symptoms (Evidence: pg no: 31, L42-L43)",
        "example": "Z09, Z86.16",
        "explanation": "Both codes required for complete follow-up documentation"
      }
    ],
    "code_categories_mentioned": [
      "Follow-up examination codes",
      "Personal history codes"
    ]
  },
  "cross_references": {
    "references_to": [
      {
        "guideline_id": "I.C.1.g.1.m",
        "title": "Post COVID-19 Condition",
        "relationship": "applies_to",
        "explanation": "Referenced for follow-up visits with residual symptoms"
      },
      {
        "guideline_id": "I.C.21.c.8",
        "title": "Factors influencing health states and contact with health services, Follow-up",
        "relationship": "related_to",
        "explanation": "General follow-up coding guidance"
      }
    ],
    "referenced_by": []
  },
  "coding_scenarios": [
    {
      "scenario_id": "COVID_FOLLOWUP_01",
      "scenario": "Patient presents for routine follow-up after COVID-19 recovery, no symptoms, negative test",
      "documentation_example": "Follow-up visit for patient who had COVID-19 three months ago, fully recovered, no residual symptoms, recent COVID test negative",
      "step_by_step": [
        "Step 1: Confirm previous COVID-19 infection",
        "Step 2: Verify no residual symptoms or conditions",
        "Step 3: Confirm negative COVID-19 test results",
        "Step 4: Assign Z09 as primary diagnosis",
        "Step 5: Assign Z86.16 as additional diagnosis"
      ],
      "correct_coding": {
        "primary_code": "Z09",
        "secondary_codes": [
          "Z86.16"
        ],
        "sequencing": "Z09 first, Z86.16 as additional",
        "rationale": "Follow-up examination code with personal history for complete documentation (Evidence: pg no: 31, L42-L43)"
      },
      "incorrect_coding": {
        "code": "Z86.16",
        "codes": [
          "Z86.16 only"
        ],
        "rationale": "Missing the follow-up examination code Z09",
        "common_mistake": "Using only personal history code without follow-up code"
      }
    }
  ],
  "procedure_links": [],
  "examples": [],
  "special_notes": {
    "warnings": [
      "Different coding applies when residual symptoms are present (Evidence: pg no: 31, L44-L45)"
    ],
    "best_practices": [
      "Use both Z09 and Z86.16 for complete follow-up documentation (Evidence: pg no: 31, L42-L43)",
      "Verify negative test results before using this coding approach (Evidence: pg no: 31, L42)"
    ],
    "common_mistakes": [
      "Using only one code instead of both required codes",
      "Not distinguishing between follow-up with and without residual symptoms"
    ],
    "tips": [
      "Check for residual symptoms to determine appropriate guideline (Evidence: pg no: 31, L44-L45)"
    ],
    "implementation_notes": [
      "Establish clear protocols for assessing residual symptoms"
    ],
    "clinical_context": [
      "Post-COVID recovery monitoring",
      "Routine follow-up care"
    ]
  },
  "search_keywords": [
    "COVID-19 follow-up",
    "Z09",
    "Z86.16",
    "resolved COVID-19",
    "negative test results",
    "post-COVID follow-up"
  ],
  "metadata": {
    "category": "chapter_specific",
    "subcategory": "COVID-19 coding",
    "complexity_level": "intermediate",
    "applies_to_settings": [
      "inpatient",
      "outpatient"
    ],
    "last_updated": "FY 2026",
    "tags": [
      "COVID-19",
      "follow-up",
      "Z_codes",
      "resolved_infection"
    ]
  },
  "page_range_processed": "pages_30_to_33"
}